Baxter Recalls Daptomycin Injection Due to Manufacturing Deviations
Baxter Healthcare is voluntarily recalling specific lots of Daptomycin Injection due to Current Good Manufacturing Practice (CGMP) deviations. The recall covers the US, Puerto Rico, and Chile.
- Product
- Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
- Category
- Drug
- Distribution
- Distributed nationwide